Australia's largest stock trading and investment forum Australia's #1 stock forum

SHC

0.00%

2.5¢ sunshine heart, inc.

stem cells, page-4

First 4 Last

Share
Profile

Follow
HC386

122 Posts.

24/03/15

21:36

Post #: 14972833
Share

Originally posted by malmanu ↑

How does C-Pulse compare to Stem Cells , are we a treatment when you fail any progress after stem cell injection. Large trial in the UK , results they say positive so far after 300 patients injected. What sort of results can they get if they are saying
‘It may be that the stem cells repair the partially damaged tissue, rather than regenerate new tissue. But whatever the process, we have had very positive results from the patients who have had the treatment so far.’

http://www.dailymail.co.uk/health/article-3005476/How-stem-cells-fix-broken-heart-just-one-jab.html

Are stem cell treatments a one off treatment or continuous after the affects wear out.

Expand

There is a whole lot of research going on using stem cells to repair the heart.
This UK study is just one of them. Neostem (Nasdaq: NBS) has completed enrolment in a Phase II study so I expect it would be much further advanced than the UK group. Here is a link to a Neostem press release which is quite interesting, especially about their share price.
http://www.neostem.com/media/press-...rther-information-regarding-phase-2-preserve/
Here also is a link to a SA article comparing Neostem stem cell therapy to Sunshine Heart’s C-Pulse.
http://seekingalpha.com/article/169...e-heart-complementary-not-competing-therapies
I would say stem cell therapy has much further to go than C-Pulse. And its efficacy has not been demonstrated in the way C-Pulse has.

Last edited by HC386: 24/03/15

SHC Price at posting: 2.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

First 4 Last

Add SHC (ASX) to my watchlist

stem cells, page-4

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Featured News